Efficacy and Safety of Telitacicept Combined With Tofacitinib for Refractory Rheumatoid Arthritis

A Study To Evaluate The Safety And Efficacy Of Tofacitinib Modified Release Tablets Compared To Tofacitinib Immediate Release Tablets In Adult Patients With Rheumatoid Arthritis

NCT02281552 ·Status: COMPLETED ·Phase: PHASE3

Methotrexate Combined With Tofacitinib in Rheumatoid Arthritis

NCT06301373 ·Status: RECRUITING ·Phase: NA

The Efficacy and Safety of Tacrolimus in Refractory Rheumatoid Arthritis Patients for 6 Months and Long-term Treatment

NCT02837978 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis

NCT05451615 ·Status: UNKNOWN ·Phase: PHASE3

Iguratimod Combined With Tofacitinib in the Treatment of Rheumatoid Arthritis

NCT05803135 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

NCT00106574 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis

NCT05572567 ·Status: COMPLETED

Patient-Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib Or Biological Disease-Modifying Antirheumatic Drugs (DMARDs) In Real Life Conditions

NCT03073109 ·Status: COMPLETED

Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis

NCT03486457 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy

NCT00106522 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of SWK002 in Patients With D2T-Rheumatoid Arthritis

NCT06503237 ·Status: RECRUITING ·Phase: NA

Study to Evaluate Safety, Tolerability, and Efficacy of GS-5718 in Participants With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-modifying Antirheumatic Drug(s) (bDMARDs) Treatment

NCT05165771 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis

NCT06146972 ·Status: RECRUITING ·Phase: PHASE4

A Study of Tocilizumab + DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

NCT00951275 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness and Safety of Tofacitinib in Korean Patients With Rheumatoid Arthritis

NCT03011281 ·Status: UNKNOWN

TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE

NCT04413617 ·Status: COMPLETED ·Phase: PHASE2

A Study of Tocilizumab (RoActemra) in Tocilizumab-Naive Participants With Rheumatoid Arthritis and Inadequate Response to Non-Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) and/or Biologic Therapy

NCT02001987 ·Status: COMPLETED ·Phase: PHASE3

A Study of Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

NCT01089023 ·Status: COMPLETED ·Phase: PHASE4

A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate Versus RoActemra/Actemra Monotherapy in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

NCT01399697 ·Status: COMPLETED ·Phase: PHASE4

Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica

NCT06172361 ·Status: RECRUITING ·Phase: PHASE3

A Study of Iguratimod in Combination With Tofacitinib in RA Patients

NCT06945666 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT Imaging

NCT02683421 ·Status: COMPLETED ·Phase: PHASE1

A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

NCT01232569 ·Status: COMPLETED ·Phase: PHASE3

Multicenter, Post-marketing, Non-interventional, Observational Study in RA Patients Treated With RoActemra/Actemra (Tocilizumab)

NCT02101307 ·Status: COMPLETED

Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders

NCT03227419 ·Status: UNKNOWN ·Phase: PHASE4